Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study.

Source:http://linkedlifedata.com/resource/pubmed/id/9857998

Download in:

View as

General Info

PMID
9857998